ATYPICAL CHRONIC MYELOID LEUKEMIA: NGS CHARACTERIZATION AND THERAPEUTIC APPROACH

被引：0
|
作者：
Luciano, L. [1 ]
Izzo, B. [2 ]
Errichiello, S. [3 ]
Rascato, G. [1 ]
Pisano, I. [3 ]
Di Folca, S. [1 ]
Aiossa, N. [1 ]
Pane, F. [1 ]
机构：
[1] Univ Naples Federico II, Hematol Dept Clin Med & Surg, Naples, Italy
[2] Univ Federico II, Dipartment Mol Med & Med Biotechnol DBBM, Naples, Italy
[3] CEINGE Adv Biotechnol, Naples, Italy
来源：
HAEMATOLOGICA | 2021年 / 106卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
D113
引用
收藏
页码：156 / 156
页数：1
相关论文
共 50 条
  • [31] Novel therapeutic approaches in chronic myeloid leukemia
    Yurttas, Nurgul Ozgur
    Eskazan, Ahmet Emre
    LEUKEMIA RESEARCH, 2020, 91
  • [32] Therapeutic use of Aldara™ in chronic myeloid leukemia
    Marleau, Annette M.
    Lipton, Jeffrey H.
    Riordan, Neil H.
    Ichim, Thomas E.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2007, 5 (1)
  • [33] RhoA: A therapeutic target for chronic myeloid leukemia
    Poonam R Molli
    Madhura B Pradhan
    Suresh H Advani
    Nishigandha R Naik
    Molecular Cancer, 11
  • [34] CHRONIC MYELOID-LEUKEMIA - A THERAPEUTIC CHALLENGE
    MUGHAL, TI
    GOLDMAN, JM
    ANNALS OF ONCOLOGY, 1995, 6 (07) : 637 - 644
  • [35] Therapeutic use of Aldara™ in chronic myeloid leukemia
    Annette M Marleau
    Jeffrey H Lipton
    Neil H Riordan
    Thomas E Ichim
    Journal of Translational Medicine, 5
  • [36] Therapeutic education of a patient with chronic myeloid leukemia
    Letarte, Nathalie
    ACTUALITES PHARMACEUTIQUES, 2012, 51 (512): : 13 - 15
  • [37] Establishment and characterization of a rare atypical chronic myeloid leukemia cell line NT-1
    Qian, Juan
    Wang, Qin-Rong
    Liu, Jie
    Jiang, Sheng-Hua
    Ni, Xiao-Qing
    Lin, Zeng-Hua
    Zhang, Ya-Ping
    Liu, Hong
    LEUKEMIA RESEARCH, 2014, 38 (09) : 1111 - 1116
  • [38] Therapeutic strategies for chronic myeloid leukemia in the chronic (stable) phase
    Goldman, JM
    SEMINARS IN HEMATOLOGY, 2003, 40 (01) : 10 - 17
  • [39] Clinical and Laboratory Characteristics of Atypical Chronic Myeloid Leukemia and Chronic Myelomonocytic Leukemia in Japanese Children
    Hama, Asahito
    Ito, Masafumi
    Hasegawa, Daisuke
    Nozawa, Kazue
    Muramatsu, Hideki
    Takahashi, Yoshiyuki
    Watanabe, Kenichiro
    Ohara, Akira
    Manabe, Atsushi
    Kojima, Seiji
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S21 - S22
  • [40] Phase 2 Study of Ruxolitinib in Patients with Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia
    Dao, Kim-Hien
    Collins, Robert H.
    Cortes, Jorge E.
    Deininger, Michael W.
    Druker, Brian J.
    Gotlib, Jason R.
    Macey, Tara Alyson
    Oh, Stephen T.
    Tyner, Jeffrey W.
    Winton, Elliott F.
    BLOOD, 2018, 132
12345